Summary

KEY FINDINGS
The Asia-Pacific insulin patch pumps market is expected to record a CAGR of 11.03% during the forecast period, 2023-2032. The increasing diabetes-related healthcare expenditure is set to boost growth opportunities in the region.
MARKET INSIGHTS
India, Vietnam, South Korea, Japan, Thailand, Australia & New Zealand, Indonesia, China, and Rest of Asia-Pacific are evaluated for the Asia-Pacific insulin patch pumps market growth assessment. In Japan, as per the IDF Diabetes Atlas 2021, around 11 million people had diabetes in 2021. Also, according to Work Bank data, in 2021, the diabetes prevalence was 6.6% among the population aged 20-79. Accordingly, the diabetes prevalence is expected to propel the demand for insulin patch pumps and raise the adoption of modern insulin pumps. Moreover, the launch of insulin pumps by leading companies is estimated to contribute to market growth. For instance, in 2018, Terumo Corporation launched MEDISAFE WITH insulin pump system in Japan.
In Vietnam, according to the World Bank data, the diabetes prevalence in 2021 was 6.1% for the population aged between 20-79. Whereas according to the IDF Diabetes Atlas, there were around 57,220 deaths attributed to diabetes in 2021. As a result, the rising diabetes prevalence and the resultant associated concerns and the growing awareness about self-care in diabetes offer growth opportunities for insulin patch pumps in Vietnam.
Furthermore, according to IDF Diabetes Atlas, in 2021, the diabetes-related expenditure per person was $3967.5 per person in New Zealand. As per the Ministry of Health, over 250,000 people have been diagnosed with diabetes. Besides, technological advancements are projected to offer lucrative growth prospects.
COMPETITIVE INSIGHTS
Some of the eminent companies in the market are CeQur SA, Tandem Diabetes Care Inc, Medtrum Technologies Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1.RESEARCH SCOPE & METHODOLOGY
1.1.STUDY OBJECTIVES
1.2.METHODOLOGY
1.3.ASSUMPTIONS & LIMITATIONS
2.EXECUTIVE SUMMARY
2.1.MARKET SIZE & ESTIMATES
2.2.MARKET OVERVIEW
2.3.SCOPE OF STUDY
2.4.CRISIS SCENARIO ANALYSIS
2.5.MAJOR MARKET FINDINGS
2.5.1.RISING OCCURRENCE OF DIABETES
2.5.2.GROWING HEALTHCARE AWARENESS
2.5.3.TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY SYSTEMS
2.5.4.INCREASING RESEARCH AND DEVELOPMENT IN MEDICAL DEVICES
3.MARKET DYNAMICS
3.1.KEY DRIVERS
3.1.1.GROWING PREVALENCE OF DIABETES
3.1.2.TECHNOLOGICAL ADVANCEMENTS IN INSULIN PATCH PUMPS
3.1.3.RISING AWARENESS ABOUT PATCH PUMPS
3.2.KEY RESTRAINTS
3.2.1.STRINGENT GOVERNMENT REGULATIONS
3.2.2.RISKS ASSOCIATED WITH THE USE OF PUMPS
3.2.3.LACK OF KNOWLEDGE LIMITS THE ADOPTION
4.KEY ANALYTICS
4.1.PARENT MARKET ANALYSIS
4.2.KEY TECHNOLOGY TRENDS
4.3.PORTER’S FIVE FORCES ANALYSIS
4.3.1.BUYERS POWER
4.3.2.SUPPLIERS POWER
4.3.3.SUBSTITUTION
4.3.4.NEW ENTRANTS
4.3.5.INDUSTRY RIVALRY
4.4.GROWTH PROSPECT MAPPING
4.5.MARKET MATURITY ANALYSIS
4.6.MARKET CONCENTRATION ANALYSIS
4.7.VALUE CHAIN ANALYSIS
4.7.1.RESEARCH AND DEVELOPMENT
4.7.2.PRODUCT MANUFACTURING
4.7.3.SALES AND DISTRIBUTION
4.8.KEY BUYING CRITERIA
4.8.1.COST
4.8.2.PRODUCT FEATURES
4.8.3.USABILITY
5.MARKET BY TYPE
5.1.DISPOSABLE
5.2.REUSABLE
6.MARKET BY DELIVERY MODE
6.1.BASAL
6.2.BOLUS
6.3.BASAL & BOLUS
7.MARKET BY DISEASE INDICATION
7.1.TYPE 1 DIABETES
7.2.TYPE 2 DIABETES
8.MARKET BY DISTRIBUTION CHANNEL
8.1.HOSPITAL PHARMACIES
8.2.RETAIL PHARMACIES
8.3.ONLINE PHARMACIES
9.GEOGRAPHICAL ANALYSIS
9.1.ASIA-PACIFIC
9.1.1.MARKET SIZE & ESTIMATES
9.1.2.ASIA-PACIFIC INSULIN PATCH PUMPS MARKET DRIVERS
9.1.3.ASIA-PACIFIC INSULIN PATCH PUMPS MARKET CHALLENGES
9.1.4.ASIA-PACIFIC INSULIN PATCH PUMPS MARKET REGULATORY FRAMEWORK
9.1.5.KEY PLAYERS IN ASIA-PACIFIC INSULIN PATCH PUMPS MARKET
9.1.6.COUNTRY ANALYSIS
9.1.6.1.CHINA
9.1.6.1.1.CHINA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.2.JAPAN
9.1.6.2.1.JAPAN INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.3.INDIA
9.1.6.3.1.INDIA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.4.SOUTH KOREA
9.1.6.4.1.SOUTH KOREA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.5.INDONESIA
9.1.6.5.1.INDONESIA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.6.THAILAND
9.1.6.6.1.THAILAND INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.7.VIETNAM
9.1.6.7.1.VIETNAM INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.8.AUSTRALIA & NEW ZEALAND
9.1.6.8.1.AUSTRALIA & NEW ZEALAND INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.9.REST OF ASIA-PACIFIC
9.1.6.9.1.REST OF ASIA-PACIFIC INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
10.COMPETITIVE LANDSCAPE
10.1.KEY STRATEGIC DEVELOPMENTS
10.1.1.ACQUISITIONS
10.1.2.PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3.PARTNERSHIPS & AGREEMENTS
10.2.COMPANY PROFILES
10.2.1.CEQUR SA
10.2.1.1.COMPANY OVERVIEW
10.2.1.2.PRODUCTS / SERVICES LIST
10.2.1.3.STRENGTHS & CHALLENGES
10.2.2.DEBIOTECH SA
10.2.2.1.COMPANY OVERVIEW
10.2.2.2.PRODUCTS / SERVICES LIST
10.2.2.3.STRENGTHS & CHALLENGES
10.2.3.EOFLOW CO LTD
10.2.3.1.COMPANY OVERVIEW
10.2.3.2.PRODUCTS / SERVICES LIST
10.2.3.3.STRENGTHS & CHALLENGES
10.2.4.F. HOFFMANN-LA ROCHE LTD
10.2.4.1.COMPANY OVERVIEW
10.2.4.2.PRODUCTS / SERVICES LIST
10.2.4.3.STRENGTHS & CHALLENGES
10.2.5.INSULET CORPORATION
10.2.5.1.COMPANY OVERVIEW
10.2.5.2.PRODUCTS / SERVICES LIST
10.2.5.3.STRENGTHS & CHALLENGES
10.2.6.MEDTRONIC PLC
10.2.6.1.COMPANY OVERVIEW
10.2.6.2.PRODUCTS / SERVICES LIST
10.2.6.3.STRENGTHS & CHALLENGES
10.2.7.MEDTRUM TECHNOLOGIES INC
10.2.7.1.COMPANY OVERVIEW
10.2.7.2.PRODUCTS / SERVICES LIST
10.2.7.3.STRENGTHS & CHALLENGES
10.2.8.TANDEM DIABETES CARE INC
10.2.8.1.COMPANY OVERVIEW
10.2.8.2.PRODUCTS / SERVICES LIST
10.2.8.3.STRENGTHS & CHALLENGES
10.2.9.TERUMO CORPORATION
10.2.9.1.COMPANY OVERVIEW
10.2.9.2.PRODUCTS / SERVICES LIST
10.2.9.3.STRENGTHS & CHALLENGES